Latest Insights on ATEN
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
Investors’ Survival Guide to the Coronavirus January 31, 2020 American Investor Today, Diversified Investments The coronavirus is spreading fear through global markets. But there is one beaten-down sector that will emerge from the global crisis even stronger. Anthony Planas reveals the No. 1 fund that every investor should add to their portfolio today.
How Big Tech’s Monopoly Threatens Free Speech January 24, 2020 Big Picture. Big Profits., Government & Politics [18-minute video] Anticompetitive practices aren’t just a danger to your wallet and health.
Buy Into the U.S. Cannabis Rally With This Operator January 24, 2020 American Investor Today, Cannabis, Investing Most Americans want legal cannabis. But the sector is down from headline risk. Anthony Planas shares his top pick for profiting from the coming rally.
Semiconductors Rally on U.S.-China Truce: Here’s 1 Bullish Play January 21, 2020 American Investor Today, Economy, Technology The semiconductor space is rallying on news that the U.S. and China reached a phase 1 trade deal. Chad Shoop looks at one beaten-down stock to capture the next rally higher. He also lets you know about an exciting new series that will turn you into an options pro in just three lessons! (20-minute video)